Cannabis lovers could get the wish of the OREO Mondelez manufacturer for CBD snacks



[ad_1]

Cannabis lovers may find their dream all over the world. The OREO Mondelez manufacturer wants to add CBD-based snacks to its product line, including Ahoy Chips, Cadbury Chocolate, Nilla Waffles and Nutter Butter.

"Yes, we are getting ready, but obviously we want to stay within the limits of legality and play the right way," CEO Dirk Van de Put told CNBC's "Squawk on the Street" broadcast on Wednesday. .

Even though he hoped that consumers would get Oreos infused with CBD, claiming that the non-psychoactive cannabis compound might not be suitable for the company's family brands, the company could add this ingredient to other products or products. even create new product lines.

Oils containing CBD (Cannabidiol) were seen in a store in Paris on June 14, 2018.

Geoffroy Van Der Hbadelt | AFP | Getty Images

A number of young companies have already started selling CBD-based foods and beverages, but large companies such as Mondelez and Coca-Cola remain on the sidelines as federal health officials badyze the new rules. governing the sector. Van de Put predicted that the ingredient would hit the traditional food market in a "not so distant future".

In December, President Donald Trump legalized most products containing CBD when he signed the agriculture bill. Since then, retailers such as Walgreens and CVS have started selling a limited number of CBD products, such as lotions and creams. However, the Food and Drug Administration prohibits adding the compound to foods or beverages. In response to Congressional pressure, the regulator has set its first date for public hearing on the subject next month.

"The space is not clear," said Van de Put. "It's a little clearer in non-food products." In food products, I hope the FDA will provide clarification in the coming months. "

Professional chefs said that foods containing CBD and cannabis were the dominant dietary pattern of 2019. The CBD in particular was generating interest for health, such as pain mitigation and management of anxiety. Little scientific research has been done to support these claims. Mondelez also examines these claims, said Van de Put.

The company's shares rose 1% Wednesday morning after Mondelez announced a profit on Tuesday night. The stock, which has a market value of $ 74.14 billion, has increased 28% since the beginning of the year.

Mondelez announced adjusted earnings of 65 cents per share, exceeding badysts' expectations by 61 cents per share. However, the company did not exceed its revenue forecast, with net sales of $ 6.54 billion. Wall Street was expecting the company to report a turnover of $ 6.55 billion.

[ad_2]
Source link